Exploring the Link Between Immune Response and Acute Viral Infections

For many years, it was thought that acute viral infections, such as COVID-19 or Zika, were the cause of neurological damage.

Exploring the Link Between Immune Response and Acute Viral Infections
McMaster University researchers Elizabeth Balint and Ali Ashkar, pictured here, have published new research that probed why some people suffer neurological damage from acute viral infections like Zika and COVID-19. Image Credit: McMaster University

However, McMaster University researchers have now found that the immune system’s reaction is actually to blame. 

Elizabeth Balint, a PhD Candidate at McMaster, and Ali Ashkar, a Professor in the Department of Medicine and holder of the Canada Research Chair in Natural Immunity and NK Cell Function, led the study, which was published in Nature Communications.

We were interested in trying to understand why so many viral infections are associated with neurological diseases. Our evidence suggests that it’s not the virus itself that causes the damage, but a unique population of T cells which are part of the immune system, that are actually responsible for the damage.”

Elizabeth Balint, PhD Candidate, McMaster University

The McMaster team concentrated on the Zika virus in order to reach this conclusion. As anticipated, during laboratory testing, researchers discovered T cells specifically engineered to eradicate Zika-infected cells. The scientists also discovered something else. 

What was interesting in our study is that although we did find some T cells specific for Zika, we identified cells that weren’t functioning like a normal T cell and were killing lots of cells that weren’t infected with Zika.”

Elizabeth Balint, PhD Candidate, McMaster University

Researchers claim that the aggressive response of these cells, known as NKG2D+CD8+ T cells, is to blame for neurological damage resulting from infections other than Zika, such as COVID-19 and even septic shock.

The body’s excessive production of inflammatory proteins known as cytokines, which in moderation aid in directing immune cells’ whereabouts and actions when they arrive in the body’s fight against infection or injury, is what causes the aggressive reaction. 

If our body’s immune cells overreact and over produce inflammatory cytokines, this condition will lead to non-specific activation of our immune cells which in turn leads to collateral damage. This can have severe consequences if it happens in the brain.”

Ali Ashkar, Professor, Chair and Study Lead Author, Department of Medicine, McMaster University

Researchers and scientists now have a new target to treat neurological diseases caused by acute viral infections thanks to this discovery. Balint has actually already discovered a potentially effective treatment.

Ashkar says, “Elizabeth has experimented with an antibody that can completely block and treat devastating neurotoxicity in the animal model, which is already in clinical trials for different uses in humans.”

Balint intends to carry out research in the hopes of developing a human-useful treatment.

Balint says, “There are a few different other viruses we’re interested in studying, which will aid us in creating the best treatment options.”

Source:
Journal reference:

Balint, E., et.al. (2024) Bystander activated CD8+ T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity. Nature Communications. doi.org/10.1038/s41467-023-44667-0

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Early T Cell Changes in Cancer Immunotherapy Patients Tied to Severe Immune Side Effects